Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports.

about

Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.

P2860

Q36382576-66FC4756-A247-4764-8431-8BC13E593AA0 Q38696205-76A967EB-C5BF-4520-8A7B-BD50530A61ED

P2860

Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports.

Item

http://www.wikidata.org/entity/Q40820466

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cabazitaxel in castration resi ...... in metastases: 3 case reports.

@en

type

Item

label

Cabazitaxel in castration resi ...... in metastases: 3 case reports.

@en

prefLabel

Cabazitaxel in castration resi ...... in metastases: 3 case reports.

@en

P1476

Cabazitaxel in castration resi ...... in metastases: 3 case reports.

@en

P2093

Carlo Buonerba

http://www.w3.org/2001/XMLSchema#string

Davide Bosso

http://www.w3.org/2001/XMLSchema#string

Giuseppe Di Lorenzo

http://www.w3.org/2001/XMLSchema#string

Livio Puglia

http://www.w3.org/2001/XMLSchema#string

Michela Izzo

http://www.w3.org/2001/XMLSchema#string

Piera Federico

http://www.w3.org/2001/XMLSchema#string

Sabino De Placido

http://www.w3.org/2001/XMLSchema#string

Tania Policastro

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.

Use of palliative radiotherapy in brain and bone metastases (VARA II study)

Are abstracts presented at the EAU meeting followed by publication in peer-reviewed journals? A critical analysis.

Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.

Peg-filgrastim and cabazitaxel in prostate cancer patients.

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.

Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.

Frequency of brain metastases from prostate cancer: an 18-year single-institution experience.

P304

228-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.12998/WJCC.V2.I6.228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pasquale Rescigno

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24945013

http://www.w3.org/2001/XMLSchema#string

P932

4061315

http://www.w3.org/2001/XMLSchema#string

Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports.

about

P2860

P2860

Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932